Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 28.09 USD -2.47% Market Closed
Market Cap: 2B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Kiniksa Pharmaceuticals Ltd
Investor Relations

Founded with a vision to tackle some of the most challenging inflammatory and autoimmune diseases, Kiniksa Pharmaceuticals Ltd. emerged as a nimble player in the competitive biotechnology landscape. This company, leveraging the vast potential of advanced scientific knowledge and biotechnological breakthroughs, focuses on developing and commercializing innovative therapies. Its portfolio is strategically designed to address unmet needs in the treatment of debilitating diseases. Central to its operations is a robust pipeline of monoclonal antibodies and cutting-edge biologics that promise new hope for patients. Guided by a commitment to rigorous clinical development and strategic collaborations, Kiniksa seeks to navigate the complexities of regulatory pathways, bringing its specialized therapeutic solutions to global markets.

The financial engine of Kiniksa's ambitious journey is fueled by a combination of strategic partnerships, successful licensing agreements, and prudent capital allocation. By forging alliances with larger pharmaceutical firms, the company gains access to invaluable resources and distribution channels while minimizing its financial risks. This collaborative approach not only expedites the development process but also amplifies market reach, ensuring that novel treatments are accessible to the patients who need them. Revenue streams are bolstered through a mix of upfront payments, milestone achievements, and royalties as its therapies progress through stages of clinical trials and, finally, into the hands of healthcare providers. This business model, one that intertwines innovation with strategic alliances, is designed to sustain growth, balance risk, and ultimately fulfill the company's mission of transforming patients’ lives.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Sanj K. Patel
CEO & Chairman of the Board
No Bio Available
Mr. Eben Tessari
Senior VP & COO
No Bio Available
Dr. John F. Paolini FACC, M.D., Ph.D.
Senior VP & Chief Medical Officer
No Bio Available
Mr. Mark Ragosa C.F.A.
Senior VP & CFO
No Bio Available
Mr. Michael R. Megna CPA
Chief Accounting Officer & Group VP of Finance
No Bio Available
Ms. Mei Jang
Senior Vice President of Technical Operations
No Bio Available
Mr. Chad Morin
Senior VP & Chief Compliance Officer
No Bio Available
Ms. Madelyn Demsky Zeylikman
SVP, General Counsel & Secretary
No Bio Available
Mr. Carsten Boess M.B.A.
Executive Vice President of Corporate Affairs
No Bio Available
Ms. Martina Struck Ph.D.
Senior Vice President of Regulatory Affairs
No Bio Available

Contacts

Address
Hamilton
Clarendon House, 2 Church Street
Contacts
+7814399100.0
www.kiniksa.com